Mitochondrial dysfunction and possible treatments in Parkinson's disease - a review

被引:33
|
作者
Shults, CW
机构
[1] Univ Calif San Diego, Dept Neurosci, San Diego Sch Med, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Neurol Serv, San Diego, CA USA
关键词
mitochondria; Parkinson's disease; creatine;
D O I
10.1016/j.mito.2004.07.028
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitochondria are central not only to the bioenergetics of the cell but also to the process of apoptotic cell death. Substantial data indicate mitochondrial dysfunction, particularly of complex I of the electron transport chain, in some patients with Parkinson's disease (PD), and it appears likely that mitochondria contribute to the pathogenic processes that occurs in this disorder. Treatments targeted at mitochondrial function hold promise to slow the progression of PD. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 50 条
  • [31] Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease
    Ebadi, M
    Sharma, SK
    ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (03) : 319 - 335
  • [32] The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
    S. B. Larsen
    Z. Hanss
    R. Krüger
    Cell and Tissue Research, 2018, 373 : 21 - 37
  • [33] Expanding insights of mitochondrial dysfunction in Parkinson's disease
    Patrick M. Abou-Sleiman
    Miratul M. K. Muqit
    Nicholas W. Wood
    Nature Reviews Neuroscience, 2006, 7 : 207 - 219
  • [34] Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson's Disease?
    Bantle, Collin M.
    Hirst, Warren D.
    Weihofen, Andreas
    Shlevkov, Evgeny
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [35] Mitochondrial dysfunction in Parkinson's disease: Is it the earliest feature?
    Murray, C. E.
    Pressey, S. N.
    Heywood, W. E.
    Hargreaves, I. P.
    Neergheen, V.
    Wauters, S.
    Palkovits, M.
    Gelpi, E.
    Troakes, C.
    Gentleman, S. M.
    Mills, K.
    Holton, J. L.
    Revesz, T.
    Gandhi, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 : 11 - 11
  • [36] Mitochondrial dysfunction – a pathogenetic factor in Parkinson’s disease
    H. Reichmann
    B. Janetzky
    Journal of Neurology, 2000, 247 (Suppl 2) : II63 - II68
  • [37] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. F.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S7 - S7
  • [38] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Onyango, Isaac G.
    NEUROCHEMICAL RESEARCH, 2008, 33 (03) : 589 - 597
  • [39] Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease
    Nguyen, Maria
    Wong, Yvette C.
    Ysselstein, Daniel
    Severino, Alex
    Krainc, Dimitri
    TRENDS IN NEUROSCIENCES, 2019, 42 (02) : 140 - 149
  • [40] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Subramaniam, Sudhakar Raja
    Chesselet, Marie-Francoise
    PROGRESS IN NEUROBIOLOGY, 2013, 106 : 17 - 32